Remove tag commercial-content
article thumbnail

3 Things Generative AI Can Do for Commercial Pharma Right Now

PM360

In commercial, issues related to Medical, Legal, and Regulatory (MLR) review compliance will need to be carefully managed as well. And while it is still too early to predict exactly how generative AI/LLMs will specifically impact pharmaceutical commercialization, several promising use cases are already emerging.

Pharma 97
article thumbnail

How to Optimize Content for SEO to Rank Higher

Healthcare Success

They also boast SEO-optimized content. To stay ahead of your competitors in organic search results and reach the right target audience, you must regularly update your content for SEO. First, let’s define content optimization. What Is Content Optimization? In this blog, I share how to do this in five steps.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

EVERSANA and Amazon Web Services Introduce Transformative Medical & Regulatory Review AI Solution

PM360

The first solution, developed by EVERSANA leveraging AWS and AWS Partner TensorIoT , addresses a time-consuming and error-prone process in the industry—medical and regulatory content approvals. The complexity of this process across healthcare is a primary barrier to delivering personalized and timely customer experiences.

Medical 52
article thumbnail

Pioneering the Path Pre- and Post-Launch Strategies

PM360

Building a Medicalized Engagement Strategy Through the course of the product lifecycle, effective content development and dissemination is an important goal, and an omnichannel approach is the way forward. Presenting a united front necessitates seamless collaboration and alignment across all divisions of the organization.

Medical 52
article thumbnail

Can gene therapies for haemophilia defend their high price tags?

Pharmaceutical Technology

In its October 28 quarterly Securities and Exchange Commission (SEC) filing, the company said that Roctavian’s commercial launch is now underway. million price tag. Editorial content is independently produced and follows the highest standards of journalistic integrity. million ($1.5 million ($1.8 million at the time).

Safety 111
article thumbnail

Mastering the Art of Presentation: Choosing the Perfect Sample Bag for Pharma Sales Success

Contrarian Sales Techniques

Durability is a key factor – these bags are built to withstand the rigors of constant travel and frequent handling, ensuring that both the bag and its contents remain in pristine condition. Options like lockable compartments and tamper-evident seals offer peace of mind and protect the contents from potential theft or tampering.

Sales 52
article thumbnail

CSL doses first patient with haemophilia B gene therapy Hemgenix

Pharmaceutical Technology

The high price tag may be hard to defend , but with lifetime treatment costs for haemophilia B reaching as high as $23m for some, the single-dose treatment could prove far more cost-effective. UniQure announced that it had received $100m from this first commercial sale milestone, on top of a $450m upfront payment.